Lifeway FoodsLWAY
LWAY
About: Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products primarily through direct sales force, brokers, and distributors.
Employees: 289
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
300% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 9
131% more capital invested
Capital invested by funds: $37.6M [Q2] → $87M (+$49.4M) [Q3]
44% more funds holding
Funds holding: 62 [Q2] → 89 (+27) [Q3]
2.71% more ownership
Funds ownership: 19.98% [Q2] → 22.69% (+2.71%) [Q3]
5% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 22
Research analyst outlook
We haven’t received any recent analyst ratings for LWAY.
Financial journalist opinion
Based on 4 articles about LWAY published over the past 30 days
Neutral
PRNewsWire
1 week ago
Lifeway Foods Announces New ProBugs Organic Kefir Distribution in More than 250 Harris Teeter Stores
MORTON GROVE, Ill. , Dec. 11, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), a leading U.S. manufacturer of kefir and fermented probiotic products, announced the distribution of its ProBugs Organic Kefir for kids at more than 250 Harris Teeter retail stores.
Neutral
Seeking Alpha
1 week ago
Lifeway Foods: Still 'In Play' Despite Two Rebuffed Takeover Offers
Lifeway Foods has rejected not one, but two takeover offers from Danone, but the kefir and fermented probiotic food products company remains "in play." The latest in an ongoing saga amongst the company's founding family may prove key in driving the company into the hands of this would-be strategic acquirer. More importantly for new and existing LWAY shareholders, this could result in Danone ultimately paying as much as $35 per share for the company.
Neutral
PRNewsWire
3 weeks ago
Lifeway Provides Additional Information Regarding Reasons for Rejecting Danone's Revised Proposal
MORTON GROVE, Ill. , Nov. 26, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) (the "Company" or "Lifeway"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today provided additional information regarding the reasons that its Board of Directors rejected the revised unsolicited proposal made on November 15, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $27.00 per share.
Neutral
PRNewsWire
4 weeks ago
Edward and Ludmila Smolyansky Call for Lifeway Foods (NASDAQ: LWAY) to Establish a Special Committee to Evaluate Danone's Offer
CHICAGO , Nov. 22, 2024 /PRNewswire/ -- Edward and Ludmila Smolyansky ("Founding Shareholders"), who together exercise voting control with respect to approximately 29.7% of the outstanding shares of common stock of Lifeway Foods, Inc. (NASDAQ: LWAY), today called for Lifeway's board of directors to take several actions, including immediately establishing an independent special committee to evaluate and negotiate a transaction with Danone or other potential buyers. This follows a proposal by Danone North America PBC to acquire all outstanding shares of Lifeway that Danone does not already own for $27 per share in cash.
Neutral
PRNewsWire
1 month ago
Lifeway Foods® Announces Latest Innovation: Probiotic Smoothie + Collagen
Leading U.S. Kefir Brand Announces Functional Beverage Made with Kefir Cultures to Support Skin Health, Immune System and the Microbiome MORTON GROVE, Ill. , Nov. 20, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, has announced its latest functional beverage innovation: Probiotic Smoothie + Collagen made with kefir cultures.
Neutral
PRNewsWire
1 month ago
LIFEWAY FOODS REJECTS REVISED UNSOLICITED PROPOSAL FROM DANONE
MORTON GROVE, Ill. , Nov. 20, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) (the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that its Board of Directors has rejected the revised unsolicited proposal made on November 15, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $27.00 per share.
Neutral
Zacks Investment Research
1 month ago
Lifeway Foods' Q3 Earnings Lag Estimates, Sales Rise 13% Y/Y
LWAY continues its impressive growth streak, marking 20 consecutive quarters of rising sales.
Neutral
PRNewsWire
1 month ago
LIFEWAY FOODS CONFIRMS RECEIPT OF REVISED, UNSOLICITED, NON-BINDING PROPOSAL FROM DANONE
MORTON GROVE, Ill. , Nov. 15, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, confirmed that it has received a revised, unsolicited, non-binding proposal from Danone North America PBC ("Danone") to acquire all outstanding shares of common stock of Lifeway it does not already own for $27.00 per share in cash.
Neutral
Seeking Alpha
1 month ago
Lifeway Foods, Inc. (LWAY) Q3 2024 Earnings Call Transcript
Lifeway Foods, Inc. (NASDAQ:LWAY ) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Company Participants Julie Smolyansky - President and Chief Executive Officer Conference Call Participants Operator Good morning. Welcome to Lifeway Foods' Third Quarter 2024 Conference Call.
Negative
Zacks Investment Research
1 month ago
Lifeway Foods (LWAY) Misses Q3 Earnings and Revenue Estimates
Lifeway Foods (LWAY) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.23 per share a year ago.
Charts implemented using Lightweight Charts™